93 related articles for article (PubMed ID: 22632607)
1. Target-based anti-angiogenic therapy in breast cancer.
Wehland M; Bauer J; Infanger M; Grimm D
Curr Pharm Des; 2012; 18(27):4244-57. PubMed ID: 22632607
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor therapy in breast cancer.
Kristensen TB; Knutsson ML; Wehland M; Laursen BE; Grimm D; Warnke E; Magnusson NE
Int J Mol Sci; 2014 Dec; 15(12):23024-41. PubMed ID: 25514409
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.
Thompson A; Brennan K; Cox A; Gee J; Harcourt D; Harris A; Harvie M; Holen I; Howell A; Nicholson R; Steel M; Streuli C
Breast Cancer Res; 2008; 10(2):R26. PubMed ID: 18371194
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression.
Toi M; Inada K; Suzuki H; Tominaga T
Breast Cancer Res Treat; 1995; 36(2):193-204. PubMed ID: 8534867
[TBL] [Abstract][Full Text] [Related]
5. Breaking down the evidence for bevacizumab in ovarian cancer.
Shu CA; Konner JA
Oncologist; 2015 Feb; 20(2):91-3. PubMed ID: 25601962
[TBL] [Abstract][Full Text] [Related]
6. A novel approach for transforming breast cancer stem cells into endothelial cells.
Mao QQ; Ji XC; Zhang JN; Teng WF; Zhou SC
Exp Ther Med; 2024 Feb; 27(2):74. PubMed ID: 38264426
[TBL] [Abstract][Full Text] [Related]
7. Three-Dimensional Growth of Prostate Cancer Cells Exposed to Simulated Microgravity.
Dietrichs D; Grimm D; Sahana J; Melnik D; Corydon TJ; Wehland M; Krüger M; Vermeesen R; Baselet B; Baatout S; Hybel TE; Kahlert S; Schulz H; Infanger M; Kopp S
Front Cell Dev Biol; 2022; 10():841017. PubMed ID: 35252204
[TBL] [Abstract][Full Text] [Related]
8. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies.
Chhichholiya Y; Suman P; Singh S; Munshi A
Med Oncol; 2021 Jul; 38(8):95. PubMed ID: 34268641
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment.
Madu CO; Wang S; Madu CO; Lu Y
J Cancer; 2020; 11(15):4474-4494. PubMed ID: 32489466
[TBL] [Abstract][Full Text] [Related]
10. Mathematical Model Predicts Effective Strategies to Inhibit VEGF-eNOS Signaling.
Wu Q; Finley SD
J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32357492
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer.
Liu J; Liu Y; Gong W; Kong X; Wang C; Wang S; Liu A
Oncol Lett; 2019 Nov; 18(5):4744-4752. PubMed ID: 31611984
[TBL] [Abstract][Full Text] [Related]
12. Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment.
Bæk Møller N; Budolfsen C; Grimm D; Krüger M; Infanger M; Wehland M; E Magnusson N
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547602
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model.
Li D; Finley SD
Front Physiol; 2019; 10():823. PubMed ID: 31379588
[TBL] [Abstract][Full Text] [Related]
14. Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer.
Kourti M; Westwell A; Jiang W; Cai J
Oncotarget; 2019 Feb; 10(10):1132-1148. PubMed ID: 30800223
[TBL] [Abstract][Full Text] [Related]
15. The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.
Li D; Finley SD
Integr Biol (Camb); 2018 Apr; 10(4):253-269. PubMed ID: 29623971
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab-Based Chemotherapy Combined with Regional Deep Capacitive Hyperthermia in Metastatic Cancer Patients: A Pilot Study.
Ranieri G; Ferrari C; Di Palo A; Marech I; Porcelli M; Falagario G; Ritrovato F; Ramunni L; Fanelli M; Rubini G; Gadaleta CD
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28684680
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment.
Liu M; Li Z; Yang J; Jiang Y; Chen Z; Ali Z; He N; Wang Z
Cell Prolif; 2016 Aug; 49(4):409-20. PubMed ID: 27312135
[TBL] [Abstract][Full Text] [Related]
18. Identifications of novel mechanisms in breast cancer cells involving duct-like multicellular spheroid formation after exposure to the Random Positioning Machine.
Kopp S; Slumstrup L; Corydon TJ; Sahana J; Aleshcheva G; Islam T; Magnusson NE; Wehland M; Bauer J; Infanger M; Grimm D
Sci Rep; 2016 May; 6():26887. PubMed ID: 27230828
[TBL] [Abstract][Full Text] [Related]
19. The Importance of Caveolin-1 as Key-Regulator of Three-Dimensional Growth in Thyroid Cancer Cells Cultured under Real and Simulated Microgravity Conditions.
Riwaldt S; Bauer J; Pietsch J; Braun M; Segerer J; Schwarzwälder A; Corydon TJ; Infanger M; Grimm D
Int J Mol Sci; 2015 Nov; 16(12):28296-310. PubMed ID: 26633361
[TBL] [Abstract][Full Text] [Related]
20. Common Effects on Cancer Cells Exerted by a Random Positioning Machine and a 2D Clinostat.
Svejgaard B; Wehland M; Ma X; Kopp S; Sahana J; Warnke E; Aleshcheva G; Hemmersbach R; Hauslage J; Grosse J; Bauer J; Corydon TJ; Islam T; Infanger M; Grimm D
PLoS One; 2015; 10(8):e0135157. PubMed ID: 26274317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
